News
Burrill & Company Announces Close of Burrill Brazil Fund I January 18, 2012 | Press Release
David Wetherell Joins Burrill & Company Venture Capital Group as Managing Director January 06, 2012 | Press Release
Global Financial Market Turmoil Overshadows Biotech Successes in 2011 January 03, 2012 | Press Release
See all NewsVenture Capital

Odyssey Thera is pioneering a pathway-based approach to drug discovery. The Company has created a comprehensive strategy for cellular systems biology and drug discovery, and is utilizing this capability both for the benefit of its pharmaceutical partners and to identify small molecules that block key cancer pathways.
For more information, please visit

